New DeepInsight ‘the next stage’ by FUJIFILM

DeepInsight ‘the next stage’ Explore the depths of ultrasound for early diagnosis with Fujifilm Healthcare. Explore the depths of ultrasound for early diagnosis. RATINGEN, Germany, Nov. 09, 2024 — FUJIFILM Healthcare Europe is proud to launch the next stage of DeepInsight, an innovative ultrasound technology that supports early

HYTN Announces Marketing Program

VANCOUVER, British Columbia, Nov. 08, 2024 — HYTN Innovations Inc. , a company specializing in the pharmaceutical development and production of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has engaged bullVestor

Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

 Two oral presentations and multiple posters on clinical andpreclinical-stage candidates to be presented at SITC, demonstratingthe strength of Immatics’ TCR-T PRAME franchise to target solid cancers ACTengine® IMA203 demonstrates 54% cORR, 12.1 months mDOR and 6 months mPFS in heavily pretreated metastatic melanoma patients and >1-year mPFS in patients with